English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

InThe New Eugenics, Judith F. Daar compellingly documents how the eugenics movement of old—intended to limit reproduction among ‘undesirables’—has far from disappeared.1 Rather, the eugenics methods have evolved hand in hand with advances in medicine and reproductive technology. Daar’s book provides a careful and easily digestible map of the ways that law, medicine, and, especially, money have perpetuated selective reproductionbyplacing limits onwhohas access to assisted reproductive technology (ART)2 to treat infertility. The same characteristics that motivated earlier eugenicists to deem someone unfit to reproduce—including socioeconomic status, race or ethnicity, marital status, disability, and sexual orientation—now underlie deprivation of access to reproductive technologies. Put simply, she writes ‘both eugenics and ART extract control over reproduction from the closed universe of the progenitors and deliver it to a world of procreative strangers’.3 What I found particularly interesting is that, in addition to the usual suspects such as doctors, these procreative strangers now include the policymakers and corporations whodeterminewhat insurancewill pay for.Theyhold thepurse strings for reproduction in an age of ART, and their decisions shine a light on ways that insurance both reflects and shapes social norms about ‘good’ reproduction and parentage. Daar artfully distills a complicated set of factors that results in differential access to reproduction and the various reasons why ART is inaccessible for the ‘less wealthy, less white, less traditional and less-abled bodied’.4 She starts by distinguishing sources of infertility as either medical or social in origin, ‘with medical infertility caused by the

Review of The New Eugenics: Selective Breeding in an Era of Reproductive Technologies